On ECHEMI
Home > Drugs > Tianjin Chase Sun Pharmaceutical Co., Ltd.
Tianjin Chase Sun Pharmaceutical Co., Ltd.
  • Founded in:

    2000-09-30
  • Country:

    China China
  • Address:

    West of Quanfa Road, Wuqing Development Zone, Tianjin New Technology Industrial Park
  • Tax NO.:

    9112000010409702XT
  • Registered Funds:

    3,004,154,837 yuan
  • Website:

  • Email:

Related Drugs
Cetirizine Hydrochloride Capsules
The main ingredient of this product is cetirizine hydrochloride, and its chemical name is (±)-2-[2-[4-[(4-chlorophenyl)benzyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride.
Name Description Content CAS NO. Registered Holders
Cetirizine dihydrochloride

This product is a selective histamine H1 receptor antagonist. Animal experiments show that this product has no obvious anticholinergic and anti-5-hydroxytryptamine effects, and is not easy to pass through the blood-cerebrospinal fluid barrier to act on the central H1 receptor. When used clinically, the central inhibitory effect is relatively mild.

More

This product is a selective histamine H1 receptor antagonist. Animal experiments show that this product has no obvious anticholinergic and anti-5-hydroxytryptamine effects, and is not easy to pass through the blood-cerebrospinal fluid barrier to act on the central H1 receptor. When used clinically, the central inhibitory effect is relatively mild.

83881-52-1 56
Tremella fuciformis enteric-coated capsules
The main ingredient of this product is Tremella polysaccharide.
Name Description Content CAS NO. Registered Holders
tremella polysaccharide

This product is a basidiomycete polysaccharide immunopotentiator, which has the effect of improving the body's immune function and increasing white blood cells. Animal experimental studies have shown that it can treat leukocytopenia caused by hydrochloric acid nitrogen mustard and cyclophosphamide in rabbits; it can promote the recovery of hematopoietic function in mice, dogs, and monkeys after gamma ray irradiation and improve the survival rate; it can significantly improve the phagocytic function of mouse reticuloendothelial cells, increase the number of monkey peripheral lymphocytes, the formation rate of E rosettes and EAC rosettes in macaque peripheral blood, increase the level of immunoglobulins and serum total complement, and has a preventive and therapeutic effect on leukocytopenia in rats caused by cyclophosphamide; it has the effect of promoting antibody production in normal and tumor-bearing mice, can activate spleen function, and enhance specific and non-specific immune responses.

More

This product is a basidiomycete polysaccharide immunopotentiator, which has the effect of improving the body's immune function and increasing white blood cells. Animal experimental studies have shown that it can treat leukocytopenia caused by hydrochloric acid nitrogen mustard and cyclophosphamide in rabbits; it can promote the recovery of hematopoietic function in mice, dogs, and monkeys after gamma ray irradiation and improve the survival rate; it can significantly improve the phagocytic function of mouse reticuloendothelial cells, increase the number of monkey peripheral lymphocytes, the formation rate of E rosettes and EAC rosettes in macaque peripheral blood, increase the level of immunoglobulins and serum total complement, and has a preventive and therapeutic effect on leukocytopenia in rats caused by cyclophosphamide; it has the effect of promoting antibody production in normal and tumor-bearing mice, can activate spleen function, and enhance specific and non-specific immune responses.

9075-53-0 0
Fasudil Hydrochloride Injection
Fasudil hydrochloride.
Name Description Content CAS NO. Registered Holders
Fasudil hydrochloride

Fasudil hydrochloride is a protein kinase inhibitor, i.e., an intracellular calcium ion antagonist. It dilates blood vessels and inhibits vasospasm by blocking the final stage of vasoconstriction, myosin light chain phosphorylation.

More

Fasudil hydrochloride is a protein kinase inhibitor, i.e., an intracellular calcium ion antagonist. It dilates blood vessels and inhibits vasospasm by blocking the final stage of vasoconstriction, myosin light chain phosphorylation.

105628-07-7 54
Fasudil Hydrochloride
Name Description Content CAS NO. Registered Holders
Fasudil hydrochloride

105628-07-7 54
Simvastatin Capsules
The main ingredient of this product is simvastatin.
Name Description Content CAS NO. Registered Holders
Simvastatin

This product itself is inactive. After oral absorption, its hydrolysis product competitively inhibits the rate-limiting enzyme hydroxymethylglutaryl coenzyme A reductase in the cholesterol synthesis process in the body, reducing the synthesis of cholesterol and increasing the synthesis of low-density lipoprotein receptors. The main site of action is in the liver, resulting in lower blood cholesterol and low-density lipoprotein cholesterol levels, moderately lower serum triglyceride levels and increased blood high-density lipoprotein levels. This has an effect on the prevention and treatment of atherosclerosis and coronary heart disease.

More

This product itself is inactive. After oral absorption, its hydrolysis product competitively inhibits the rate-limiting enzyme hydroxymethylglutaryl coenzyme A reductase in the cholesterol synthesis process in the body, reducing the synthesis of cholesterol and increasing the synthesis of low-density lipoprotein receptors. The main site of action is in the liver, resulting in lower blood cholesterol and low-density lipoprotein cholesterol levels, moderately lower serum triglyceride levels and increased blood high-density lipoprotein levels. This has an effect on the prevention and treatment of atherosclerosis and coronary heart disease.

79902-63-9 63
  • 1
  • 2
  • Go to Page Go
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.